Ligand-Based Virtual Screening (LBVS)

The foundational LBVS technique that encodes molecular structure into a fixed-length bit string for rapid comparison. Common fingerprints include MACCS keys (166-bit structural keys), ECFP4 (circular fingerprints capturing atom neighborhoods up to diameter 4), and Atom Pairs. Similarity is quantified using the Tanimoto coefficient, where a score > 0.7 typically indicates meaningful structural resemblance.

• ECFP4 excels at scaffold hopping by capturing pharmacophoric features
• MACCS keys provide interpretable substructure-based comparisons
• Fingerprint-based screening can process millions of compounds per second on modern hardware

An abstraction technique that defines the essential 3D spatial arrangement of steric and electronic features required for biological activity. A pharmacophore model consists of feature types—hydrogen bond donors/acceptors, hydrophobic centroids, aromatic rings, and positive/negative ionizable groups—positioned with distance and angle constraints.

• Enables scaffold hopping by ignoring core structure and focusing on functional group topology
• Models can be derived from a single active ligand or an ensemble alignment of multiple actives
• 3D pharmacophore searches are more computationally intensive than 2D fingerprinting but capture conformational requirements

A regression or classification approach that mathematically correlates molecular descriptors with biological activity. Descriptors span 1D (logP, molecular weight), 2D (topological indices, connectivity), and 3D (CoMFA fields, VolSurf). Modern implementations use Random Forest, Support Vector Machines, and Gradient Boosting algorithms.

• Applicability Domain analysis is critical to avoid extrapolating predictions on dissimilar chemotypes
• 3D-QSAR methods like CoMFA visualize favorable/unfavorable electrostatic and steric fields
• QSAR models require rigorous cross-validation and external test set validation to ensure predictive power

A technique that compares molecules based on their volumetric shape and electrostatic potential similarity, independent of 2D structure. Algorithms like ROCS (Rapid Overlay of Chemical Structures) perform Gaussian-based volume overlap calculations to quantify shape Tanimoto scores.

• Captures bioisosteric replacements that 2D fingerprints miss
• Requires high-quality conformer generation as preprocessing—typically 50-200 low-energy conformers per molecule
• Electrostatic similarity (EON scoring) can be combined with shape overlap to refine hit lists
• Particularly effective for targets with well-characterized shape pharmacophores

Supervised learning approaches that train on known active/inactive compounds to produce a probability score for virtual screening ranking. Architectures include Graph Neural Networks (GNNs) that operate directly on molecular graphs, Message Passing Neural Networks for learning atomic representations, and Siamese networks for one-shot similarity learning.

• Deep learning models can learn complex, non-linear structure-activity relationships beyond traditional fingerprints
• Requires careful data curation to avoid false negatives in training sets
• Transfer learning from large-scale chemical property prediction tasks can improve performance on small target-specific datasets

Methods that compare molecules based on their Molecular Electrostatic Potential (MEP) surfaces and molecular interaction fields. Tools like FLAP and COBRA generate GRID-based interaction fields using probes representing different chemical functionalities (hydrophobic, H-bond donor/acceptor).

• Captures subtle electronic effects critical for binding that shape-only methods overlook
• Carbo similarity index quantifies MEP overlap between aligned molecules
• Field-based approaches are particularly valuable for targets where electrostatic complementarity dominates binding affinity
• Computationally more expensive than 2D methods but less demanding than full docking

A computational modeling method that establishes a mathematical relationship between the structural features of a set of chemicals and their biological activity. In LBVS, QSAR models are trained on known active ligands to predict the activity of novel compounds.

• 2D-QSAR: Uses physicochemical descriptors like logP, molar refractivity, and electronic parameters.
• 3D-QSAR: Methods like CoMFA and CoMSIA map steric and electrostatic fields around aligned ligands.
• Machine Learning QSAR: Modern approaches use Random Forests, SVMs, and deep neural networks on high-dimensional fingerprints for superior predictive power.

A technique for encoding the structural features of a molecule into a fixed-length binary bit string or vector. Fingerprints are the foundational representation for similarity searching in LBVS, enabling rapid comparison of chemical structures.

• MACCS Keys: A predefined set of 166 structural keys encoding the presence or absence of specific functional groups.
• Morgan/Circular Fingerprints: Extended-connectivity fingerprints (ECFP) that encode atom neighborhoods up to a specified radius, widely used for scaffold hopping.
• Path-based Fingerprints: Encode all linear and branched paths of atoms up to a given length.

The most widely used metric for comparing two molecular fingerprints in LBVS. Calculated as the ratio of shared features to the total number of features, with values ranging from 0 (no similarity) to 1 (identical).

• Formula: T(A,B) = c / (a + b - c), where c is the number of bits set in both fingerprints.
• Typical Thresholds: A Tanimoto score > 0.85 often indicates close structural analogs; > 0.7 is a common cutoff for hit expansion.
• Limitation: Can be biased by molecular size; larger molecules tend to have higher similarity scores by chance.

The computational construction of an abstract representation of the essential steric and electronic features required for a ligand to interact with a specific biological target. Pharmacophore models are used in LBVS to search for compounds with a similar 3D arrangement of key interaction features.

• Features: Include hydrogen bond donors/acceptors, hydrophobic regions, aromatic rings, and positive/negative ionizable groups.
• Ligand-Based Pharmacophores: Built by aligning active ligands to identify common features without target structure.
• Screening: A 3D database search identifies molecules that can adopt a conformation matching the pharmacophore query.

The identification of novel chemotypes with a different core molecular scaffold that retain the biological activity of a known active compound. A primary goal of LBVS is to enable scaffold hopping to circumvent patents, improve ADMET properties, or discover new chemical matter.

• Pharmacophore-based hopping: Uses 3D feature similarity rather than 2D structure to find diverse scaffolds.
• Shape-based hopping: Methods like ROCS compare molecular shape and electrostatic potential to find bioisosteric replacements.
• Machine learning approaches: Generative models can be trained to produce novel scaffolds with desired activity profiles.

A pair of structurally similar molecules with a large difference in biological activity. Activity cliffs are critical for understanding structure-activity relationships and refining predictive models in LBVS.

• Definition: Typically defined by a Tanimoto similarity > 0.7 and a potency difference > 100-fold.
• Importance: Reveals that small structural changes can dramatically alter activity, highlighting pharmacophoric hot spots.
• Model Sensitivity: QSAR and machine learning models must be evaluated on their ability to predict activity cliffs, as they represent the most challenging test cases.